Adam Taylor Sullivan - Aug 16, 2024 Form 4 Insider Report for Core Scientific, Inc./tx (CORZ)

Role: Chief Executive Officer, Director
Signature: /s/ Todd DuChene, as Attorney-in-Fact
Stock symbol: CORZ
Transactions as of: Aug 16, 2024
Transactions value $: $953
Form type: 4
Date filed: 8/20/2024, 07:44 PM
Previous filing: Jun 17, 2024
Next filing: Jan 3, 2025

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CORZ	Common Stock	Exercise of in-the-money or at-the-money derivative security	$953	+95.3K	+2.41%	$0.01	4.06M	Aug 16, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CORZ	Tranche 2 Warrants	Exercise of in-the-money or at-the-money derivative security	$0	-95.3K	-100%	$0.00	0	Aug 16, 2024	Common Stock	95.3K	$0.01	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person received 95,303 Tranche 2 Warrants on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC, which acquisition was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.
F2	Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.

Content

The Reporting Person received 95,303 Tranche 2 Warrants on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC, which acquisition was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.

Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.